ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BFRG vs INM // ALTMAN Z-SCORE & DEBT/EQUITY

Bullfrog AI Holdings Inc. (NASDAQ) VS. InMed Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: BFRG 1 — INM 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BFRG VS. INM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BFRG INM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 18.80% 34.50% -15.70 INM /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) — 7.50% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 4/9 -1.00 INM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.9 67.0 -23.10 INM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $9.0M $8.8M $252.8K BFRG /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BFRG REV INM REV BFRG GROSS % INM GROSS % BFRG FCF INM FCF
FY 2025 $116.7K $4.9M 18.8% 34.5% -$5.5M -$8.1M
FY 2024 $20.3M $4.6M — 23.9% -$5.6M -$7.0M
FY 2023 $65.0K $4.1M — — -$6.0M -$7.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BFRG // BETA —
INM // BETA —